Skip to main content

Articles

Page 4 of 15

  1. Durvalumab plus gemcitabine and cisplatin has a significant clinical benefit for advanced biliary tract cancer (BTC). However, the high price of durvalumab warrants an exploration of the economics.

    Authors: Qiuling Zhao, Ruixiang Xie, Wanfu Zhong, Wenbin Liu, Ting Chen, Xiuliang Qiu and Lin Yang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:19
    Content type: Research Published on:

  2. Mental illnesses account for a considerable proportion of the global burden of disease. Economic evaluation of public policies and interventions aimed at mental health is crucial to inform decisions and improv...

    Authors: Igor Larrañaga, Oliver Ibarrondo, Lorea Mar-Barrutia, Myriam Soto-Gordoa and Javier Mar
    Citation: Cost Effectiveness and Resource Allocation 2023 21:18
    Content type: Research Published on:

  3. Since Shiraz Transplant Center is one of the major transplant centers in Iran and the Middle East, this study was conducted to evaluate outcomes of the applied policies on COVID-19 detection and management.

    Authors: Mojtaba Shafiekhani, Tahmoores Niknam, Seyed Ahmad Tara, Parviz Mardani, Khatereh Mirzad Jahromi, Sedigheh Jafarian, Sara Arabsheybani, Halimeh Negahban, Majid Hamzehnejadi, Zahra Zare, Khadijeh Ghaedi Ghalini, Ali Ghasemnezhad, Mahmoud Akbari, Reza Shahriarirad and Seyed Ali MalekHosseini
    Citation: Cost Effectiveness and Resource Allocation 2023 21:17
    Content type: Research Published on:

  4. Cost-effectiveness analysis plays a key role in evaluating health systems and services. Coronary artery disease is one of the primary health concerns worldwide. This study sought to compare the cost-effectiven...

    Authors: NourolHoda Fakhrzad, Mohsen Barouni, Reza Goudarzi, Javad Kojuri, Yunes Jahani and Mohammad Tasavon Gholamhoseini
    Citation: Cost Effectiveness and Resource Allocation 2023 21:16
    Content type: Research Published on:

  5. Essential Emergency and Critical Care (EECC) is a novel approach to the care of critically ill patients, focusing on first-tier, effective, low-cost, life-saving care and designed to be feasible even in low-re...

    Authors: Lorna Guinness, Angela Kairu, August Kuwawenaruwa, Karima Khalid, Khamis Awadh, Vincent Were, Edwine Barasa, Hiral Shah, Peter Baker, Carl Otto Schell and Tim Baker
    Citation: Cost Effectiveness and Resource Allocation 2023 21:15
    Content type: Research Published on:

  6. Emerging evidence suggests that structured and progressive exercise underpinned by a cognitive behavioural approach can improve functional outcomes in patients with neurogenic claudication (NC). However, evide...

    Authors: Mandy Maredza, Kamran Khan, Ioana R. Marian, Susan J. Dutton, Esther Williamson, Sarah E. Lamb and Stavros Petrou
    Citation: Cost Effectiveness and Resource Allocation 2023 21:14
    Content type: Research Published on:

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:24

  8. Rehabilitation is an essential medical service for patients who have suffered acute stroke. Although the effectiveness of 7-days-per-week rehabilitation schedule has been studied in comparison with 5- or 6-day...

    Authors: Yasuhiro Morii, Kagari Abiko, Toshiya Osanai, Jiro Takami, Takumi Tanikawa, Kensuke Fujiwara, Kiyohiro Houkin and Katsuhiko Ogasawara
    Citation: Cost Effectiveness and Resource Allocation 2023 21:12
    Content type: Research Published on:

  9. The aims of this study was to appraise the health economic evidence for adjuvant chemotherapy (AC) strategies in stage II and III colon cancer (CC) and identify gaps in the available evidence that might inform...

    Authors: Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman and Koen Degeling
    Citation: Cost Effectiveness and Resource Allocation 2023 21:11
    Content type: Research Published on:

  10. Renal cell carcinoma (RCC) is the most common type of kidney cancer. VEGF inhibitors and mTORs are the most common therapeutic options among the different classes of available treatments. In this study, the ef...

    Authors: Zahra Goudarzi, Mehrdad Mostafavi, Mahmood Salesi, Mojtaba Jafari, Iman Mirian, Amir Hashemi Meshkini, Khosro Keshavarz and Younes Ghasemi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:10
    Content type: Review Published on:

  12. Congenital cytomegalovirus (cCMV) infection can cause severe neurological damage, growth retardation, hearing loss, and microcephaly in infants. We aimed at assessing healthcare costs of infants with recorded ...

    Authors: Anna-Janina Stephan, Marion de Lepper, Regine Wölle, Agnes Luzak, Wei Wang, Christian Jacob, Kim Maren Schneider, Horst Buxmann, Rangmar Goelz, Klaus Hamprecht, Peter Kummer, Susanne Modrow, Wolfgang Greiner and Miriam Reuschenbach
    Citation: Cost Effectiveness and Resource Allocation 2023 21:8
    Content type: Research Published on:

  13. This article aims to summarize the development and challenges of real-world data (RWD) and real-world evidence (RWE) in China and introduce a unique opportunity for medical devices to gain accelerated regulato...

    Authors: Jiahe Li, Lichang Liu, Haijun Cao, Mei Yang and Xin Sun
    Citation: Cost Effectiveness and Resource Allocation 2023 21:7
    Content type: Review Published on:

  14. Atezolizumab has recently been approved for first-line treatment of high PD-L1 expression metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with no EGFR or ALK mutations, on the basis of the IMpower110 tr...

    Authors: Dolores Isla, Marta Lopez-Brea, María Espinosa, Natalia Arrabal, Diego Pérez-Parente, David Carcedo and Reyes Bernabé-Caro
    Citation: Cost Effectiveness and Resource Allocation 2023 21:6
    Content type: Research Published on:

  15. Bladder cancer is one of the most prevalent and costly cancers in the world. Estimating the economic burden of bladder cancer is essential for allocating resources to different sectors of health systems and de...

    Authors: Mehdi Raadabadi, Rajabali Daroudi, Kazem Zendehdel, Ali Akbar Haghdoost, Mohammad Reza Ebadzadeh and Hamideh Rashidian
    Citation: Cost Effectiveness and Resource Allocation 2023 21:5
    Content type: Research Published on:

  16. Stereotactic ablative radiotherapy (SABR) is recommended as first-choice treatment to inoperable early-stage non-small cell lung cancer (NSCLC). However, it is not widely adopted in developing countries, and i...

    Authors: Fernando Henrique de Albuquerque Maia, Luciana Martins Rozman, Heloisa de Andrade Carvalho and Patrícia Coelho de Soárez
    Citation: Cost Effectiveness and Resource Allocation 2023 21:4
    Content type: Review Published on:

  17. Total hip arthroplasty (THA) is the most common treatment for primary and secondary end-stage hip osteoarthritis (OA). Almost 20% of all patients undergoing primary THA suffer from bilateral hip OA and, conseq...

    Authors: Pierluigi Pironti, Andrea Ambrosanio, Valeria Vismara, Marco Viganò, Eugenia Bucci, Paolo Sirtori, Giuseppe M Peretti and Laura Mangiavini
    Citation: Cost Effectiveness and Resource Allocation 2023 21:3
    Content type: Research Published on:

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:9

  18. It can be challenging to diagnose the cause of a patient’s dizziness. Patients face significant delays before receiving a correct diagnosis as they will undergo many diagnostic tests under several different me...

    Authors: John S Phillips and Jacob Newman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:2
    Content type: Research Published on:

  19. Image-guided system (IGS) has been gradually applied in the field of rhinology, making functional endoscopic sinus surgery (FESS) a truly minimally invasive and precise surgery. This study was based on real-wo...

    Authors: Zaixing Wang, Chunling Liu, Baoying Tan, Guoqing Sun, Poucheok Pang, Kangchen lv, Hui Xie, Xiong Ou, Xianhai Zeng and Jianwei Xuan
    Citation: Cost Effectiveness and Resource Allocation 2023 21:1
    Content type: Research Published on:

  20. Unequal utilization of medical services will have a significant impact on the consumption of resources entitled through health insurance claims of patients. With the proposal of the goal of Healthy China, it i...

    Authors: Lele Li, Xiaotong He, Yixuan Li, Xiangyu Chen, Xue Wang and Chunhou Li
    Citation: Cost Effectiveness and Resource Allocation 2022 20:74
    Content type: Research Published on:

  21. Has the medical arms race (MAR) increased healthcare expenditures? Existing literature has yet to draw a consistent conclusion. Hence, this study aims to reexamine the relationship between the MAR and medical ...

    Authors: Paicheng Liu, Xue Gong, Qianhui Yao and Qiong Liu
    Citation: Cost Effectiveness and Resource Allocation 2022 20:73
    Content type: Research Published on:

  22. Surgical lung resection involves a critical task of stapled ligation and transection of major vascular structures and tissue, which may lead to bleeding and complications. A newer powered stapling system with ...

    Authors: Chongzhi Gan, Fuchun Zeng, Wei Cong, Tiange Tang and Gang Feng
    Citation: Cost Effectiveness and Resource Allocation 2022 20:72
    Content type: Research Published on:

  23. Governments in Latin America are constantly facing the problem of managing scarce resources to satisfy alternative needs, such as housing, education, food, and healthcare security. Those needs, combined with i...

    Authors: Arcadio A. Cerda, Leidy Y. García, Jennifer Rivera-Arroyo, Andrés Riquelme, Joao Paulo Teixeira and Mihajlo Jakovljevic
    Citation: Cost Effectiveness and Resource Allocation 2022 20:71
    Content type: Review Published on:

  24. Preparation and financing of treatments, control of disease by limited resources, are known as the most important challenges encountered by the policy-makers involved in an epidemic outbreak. Therefore, the pr...

    Authors: Zeynab Farhadi, Morteza Salemi and Mohammad Ali Jahani
    Citation: Cost Effectiveness and Resource Allocation 2022 20:70
    Content type: Research Published on:

  25. Multiple myeloma is an incurable haematological malignancy that is associated with a high probability of relapse. The survival of relapsed patients has been greatly improved by the development of novel drugs s...

    Authors: Lineo Marie Matsela, Susan Cleary and Thomas Wilkinson
    Citation: Cost Effectiveness and Resource Allocation 2022 20:69
    Content type: Research Published on:

  26. The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indir...

    Authors: Saeed Mohammadpour, Samira Soleimanpour, Javad Javan-Noughabi, Nasrin Aboulhasanbeigi Gallehzan, Ali Aboutorabi, Reza Jahangiri, Rafat Bagherzadeh, Julia F. Gorman and Ali Nemati
    Citation: Cost Effectiveness and Resource Allocation 2022 20:68
    Content type: Review Published on:

  27. In the past decades, highly innovative treatments in the field of diffuse large B-cell lymphoma (DLBCL) became available in clinical practice. The aim of this study was to assess the cost–benefit relation of t...

    Authors: Florian Jakobs, Julia Jeck, Paymon Ahmadi, Anna Kron and Florian Kron
    Citation: Cost Effectiveness and Resource Allocation 2022 20:67
    Content type: Research Published on:

  28. The present study aimed to examine the cost-effectiveness of fractional flow reserve (FFR) versus angiography in treating borderline coronary lesions in patients with coronary artery stenosis in Iran. Cardiova...

    Authors: Khosro Keshavarz, Rita Rezaee, Elahe Esmaili, Roohollah Mansouri, Abdosaleh Jafari, Azadeh Erami, Hamid Talebianpour, Ricardo Fonseca and Mozhgan Fardid
    Citation: Cost Effectiveness and Resource Allocation 2022 20:66
    Content type: Research Published on:

  29. An inefficient health system wastes scarce resources even if it makes considerable gains in accountability and equity. Such a system is expected to perform better. Therefore, it is vital to examine the current...

    Authors: Siamak Aghlmand, Sadegh Feizollahzadeh, Behrouz Fathi, Hasan Yusefzadeh and Mina Alinejhad
    Citation: Cost Effectiveness and Resource Allocation 2022 20:65
    Content type: Research Published on:

  31. Autoimmune thyroid diseases are the most common diseases in humans. Their pathogenesis is complex, pushing patients to search different ways of alleviating their effects, one of which is diet change. The aim o...

    Authors: Ewa Czubek, Klaudia Alcer, Mirjana Varjacic and Piotr Romaniuk
    Citation: Cost Effectiveness and Resource Allocation 2022 20:63
    Content type: Research Published on:

  32. This study was aimed to systematically review published economic studies to determine whether dapagliflozin, a sodium-glucose co-transporter inhibitor, plus standard care therapy (SCT) is cost-effective in hea...

    Authors: Ghader Mohammadnezhad, Behniya Azadmehr, Mehdi Mirheidari and Nazila Yousefi
    Citation: Cost Effectiveness and Resource Allocation 2022 20:62
    Content type: Review Published on:

  33. To assess the cost-effectiveness of the delayed-release device of dexamethasone compared with aflibercept in the treatment of patients with naïve diabetic macular edema (DME) from a societal perspective in the...

    Authors: Paula Montes Rodríguez, Javier Mateo Gabás, Olivia Esteban Floría, Ana Honrubia Grijalbo and Francisco J. Ascaso Puyuelo
    Citation: Cost Effectiveness and Resource Allocation 2022 20:61
    Content type: Research Published on:

  34. Numerous studies have shown the effectiveness of testing for hepatitis B (HBV) and hepatitis C (HCV) in emergency departments (ED), due to the elevated prevalence amongst attendees. The aim of this study was t...

    Authors: Jack Williams, Peter Vickerman, Elizabeth Smout, Emma E. Page, Khine Phyu, Mark Aldersley, Gaia Nebbia, Sam Douthwaite, Laura Hunter, Murad Ruf and Alec Miners
    Citation: Cost Effectiveness and Resource Allocation 2022 20:60
    Content type: Research Published on:

  35. There is level 1 evidence for cerebral thrombectomy with thrombolysis in acute large vessel occlusion. Many hospitals are now contemplating setting up this life-saving service. For the hospital, however, the f...

    Authors: Iris Q. Grunwald, Viola Wagner, Anna Podlasek, Gouri Koduri, Paul Guyler, Stephen Gerry, Sweni Shah, Horst Sievert, Aarti Sharma, Shrey Mathur, Klaus Fassbender, Kaveh Shariat, Graeme Houston, Avinash Kanodia and Silke Walter
    Citation: Cost Effectiveness and Resource Allocation 2022 20:59
    Content type: Research Published on:

  36. Associations between the COVID-19 pandemic and hospitalizations have not been studied Iran. This study aimed to examine the impact of the COVID-19 pandemic on hospital admissions for nine categories of disease...

    Authors: Sina Ahmadi, Ali Kazemi-Karyani, Nasim Badiee, Sarah Byford, Ali Mohammadi, Bakhtiar Piroozi and Satar Rezaei
    Citation: Cost Effectiveness and Resource Allocation 2022 20:58
    Content type: Comment Published on:

  37. The state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy...

    Authors: Charles C. Ezenduka, Abudulahi Namadi, Dahiru Tahir, Uzoma Nwosu and Shuaibu N. Musa
    Citation: Cost Effectiveness and Resource Allocation 2022 20:57
    Content type: Research Published on:

  38. Empirical estimates of health system opportunity costs have been suggested as a basis for the cost-effectiveness threshold to use in Health Technology Assessment. Econometric methods have been used to estimate...

    Authors: Karla Hernandez-Villafuerte, Bernarda Zamora, Yan Feng, David Parkin, Nancy Devlin and Adrian Towse
    Citation: Cost Effectiveness and Resource Allocation 2022 20:56
    Content type: Research Published on:

  39. This study was an ex-ante cost-utility analysis of deemed consent legislation for deceased organ donation in Nova Scotia, a province in Canada. The legislation became effective in January 2021. The study's obj...

    Authors: Prosper Koto, Karthik Tennankore, Amanda Vinson, Kristina Krmpotic, Matthew J. Weiss, Chris Theriault and Stephen Beed
    Citation: Cost Effectiveness and Resource Allocation 2022 20:55
    Content type: Research Published on:

  40. Health Technology Assessment (HTA) has been widely recognized as informing healthcare decision-making, and interest in HTA of medical devices has been steadily increasing. How does the assessment of medical de...

    Authors: Jian Ming, Yunzhen He, Yi Yang, Min Hu, Xinran Zhao, Jun Liu, Yang Xie, Yan Wei and Yingyao Chen
    Citation: Cost Effectiveness and Resource Allocation 2022 20:54
    Content type: Review Published on:

  41. The prevalence of heart failure (HF) is increasing in the ageing world population, and its burden on the medical and health economic fields is enormous. Rehabilitation is an essential component of the nonpharm...

    Authors: Kotomi Sakai, Ryo Momosaki and Eri Hoshino
    Citation: Cost Effectiveness and Resource Allocation 2022 20:53
    Content type: Comment Published on:

  42. Accurate information on the cost determinants in the COVID-19 patients could provide policymakers a valuable planning tool for dealing with the future COVID-19 crises especially in the health systems with limi...

    Authors: Vajihe Ramezani-Doroh, Leili Tapak, Yadollah Hamidi, Saeid Bashirian, Ali Reza Soltanian, Mahyar Motaghed, Ebrahim Ghelichkhani and Elaheh Talebi-Ghane
    Citation: Cost Effectiveness and Resource Allocation 2022 20:52
    Content type: Research Published on:

  43. The objective of this paper is to assess the economic profile of Enzyme Replacement Therapy (ERT) to symptomatic patients with Pompe, Fabry, Gaucher disease and Lysosomal acid lipase (LAL) deficiency.

    Authors: Eleni Ioanna Katsigianni and Panagiotis Petrou
    Citation: Cost Effectiveness and Resource Allocation 2022 20:51
    Content type: Review Published on:

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2022 20:64

  44. Given the human and economic cost of the COVID-19 pandemic, protecting healthcare workers (HCW) and ensuring continuity of care is critical. The aim of this study is to evaluate the cost-effectiveness of diffe...

    Authors: Roberto Benoni, Irene Campagna, Francesca Moretti and Stefano Tardivo
    Citation: Cost Effectiveness and Resource Allocation 2022 20:50
    Content type: Research Published on:

  45. Despite the high HIV associated burden, Mozambique lacks data on HIV counselling and testing (HCT) costs. To help guide national HIV/AIDS programs, we estimated the cost per test for voluntary counselling and ...

    Authors: Jun Hao Choo, Elisa Lopez-Varela, Laura Fuente-Soro, Orvalho Augusto, Charfudin Sacoor, Ariel Nhacolo, Stanley Wei, Denise Naniche, Ranjeeta Thomas and Elisa Sicuri
    Citation: Cost Effectiveness and Resource Allocation 2022 20:49
    Content type: Research Published on:

  46. In Germany, CRT devices with defibrillator capability (CRT-D) have become the predominant treatment strategy for patients with heart failure and cardiac dyssynchrony. However, according to current guidelines, ...

    Authors: Moritz Hadwiger, Laura Schumann, Nora Eisemann, Nikolaos Dagres, Gerhard Hindricks, Janina Haug, Michael Wolf, Ursula Marschall, Alexander Katalinic and Fabian-Simon Frielitz
    Citation: Cost Effectiveness and Resource Allocation 2022 20:48
    Content type: Research Published on:

  47. Despite ample international knowledge on cost-effectiveness of total knee arthroplasty (TKA), it has never been a subject of investigation in Kazakhstan or other post-Soviet economies. Our study aimed to carry...

    Authors: Dinara Serikova-Esengeldina, Natalya Glushkova, Gulzada Abdushukurova, Akmaral Mussakhanova, Ainur Mukhamejanova, Zaituna Khismetova, Dmitry Bokov, Alexandr Ivankov, Maiya Goremykina and Yuliya Semenova
    Citation: Cost Effectiveness and Resource Allocation 2022 20:47
    Content type: Research Published on:

  48. Drug reimbursement decisions are often made based on a price set by the manufacturer. In some cases, this price leads to public and scientific debates about whether its level can be justified in relation to it...

    Authors: Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer and Werner B. F. Brouwer
    Citation: Cost Effectiveness and Resource Allocation 2022 20:46
    Content type: Research Published on:

  49. This study aimed to examine the economic and clinical benefits of a new powered circular stapler for left-sided colorectal construction in China.

    Authors: Junwei Bai, Yingnan Zhao, Hong Liang, Junmeng Li and Chao Zhang
    Citation: Cost Effectiveness and Resource Allocation 2022 20:45
    Content type: Research Published on:

  50. The objective of this study is the evaluation of routine chest radiography following the placement of Implantable venous access port catheter (IVAPC) central lines using combined ultrasound and fluoroscopic gu...

    Authors: Hamed Ghoddusi Johari, Mohammad Reza Saki, Amirhossein Erfani, Reza Shahriarirad and Keivan Ranjbar
    Citation: Cost Effectiveness and Resource Allocation 2022 20:43
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.7
    5-year Journal Impact Factor: 2.1
    Source Normalized Impact per Paper (SNIP): 0.749
    SCImago Journal Rank (SJR): 0.610

    Speed 2023
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 157

    Usage 2023
    Downloads: 595,859
    Altmetric mentions: 2,584

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us